BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Lung cancer AND MYCL, LMYC, 4610, MYCL1, ENSG00000116990 AND Prognosis
27 results:

  • 1. Molecular Subtypes of Extra-pulmonary Neuroendocrine Carcinomas Identified by the Expression of Neuroendocrine Lineage-Specific Transcription Factors.
    Metovic J; La Salvia A; Rapa I; Napoli F; Birocco N; Pia Bizzi M; Garcia-Carbonero R; Ciuffreda L; Scagliotti G; Papotti M; Volante M
    Endocr Pathol; 2022 Sep; 33(3):388-399. PubMed ID: 35608806
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. MYC, mycl, and MYCN as therapeutic targets in lung cancer.
    Massó-Vallés D; Beaulieu ME; Soucek L
    Expert Opin Ther Targets; 2020 Feb; 24(2):101-114. PubMed ID: 32003251
    [No Abstract]    [Full Text] [Related]  

  • 3. Longitudinal Cell-Free DNA Analysis in Patients with Small Cell lung cancer Reveals Dynamic Insights into Treatment Efficacy and Disease Relapse.
    Almodovar K; Iams WT; Meador CB; Zhao Z; York S; Horn L; Yan Y; Hernandez J; Chen H; Shyr Y; Lim LP; Raymond CK; Lovly CM
    J Thorac Oncol; 2018 Jan; 13(1):112-123. PubMed ID: 28951314
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. lung neuroendocrine tumours: deep sequencing of the four World Health Organization histotypes reveals chromatin-remodelling genes as major players and a prognostic role for TERT, RB1, MEN1 and KMT2D.
    Simbolo M; Mafficini A; Sikora KO; Fassan M; Barbi S; Corbo V; Mastracci L; Rusev B; Grillo F; Vicentini C; Ferrara R; Pilotto S; Davini F; Pelosi G; Lawlor RT; Chilosi M; Tortora G; Bria E; Fontanini G; Volante M; Scarpa A
    J Pathol; 2017 Mar; 241(4):488-500. PubMed ID: 27873319
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Comprehensive genomic analysis identifies SOX2 as a frequently amplified gene in small-cell lung cancer.
    Rudin CM; Durinck S; Stawiski EW; Poirier JT; Modrusan Z; Shames DS; Bergbower EA; Guan Y; Shin J; Guillory J; Rivers CS; Foo CK; Bhatt D; Stinson J; Gnad F; Haverty PM; Gentleman R; Chaudhuri S; Janakiraman V; Jaiswal BS; Parikh C; Yuan W; Zhang Z; Koeppen H; Wu TD; Stern HM; Yauch RL; Huffman KE; Paskulin DD; Illei PB; Varella-Garcia M; Gazdar AF; de Sauvage FJ; Bourgon R; Minna JD; Brock MV; Seshagiri S
    Nat Genet; 2012 Oct; 44(10):1111-6. PubMed ID: 22941189
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. A 5'-region polymorphism modulates promoter activity of the tumor suppressor gene MFSD2A.
    Colombo F; Falvella FS; Galvan A; Frullanti E; Kunitoh H; Ushijima T; Dragani TA
    Mol Cancer; 2011 Jul; 10():81. PubMed ID: 21736709
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Meta-analysis suggests association of L-myc EcoRI polymorphism with cancer prognosis.
    Spinola M; Pedotti P; Dragani TA; Taioli E
    Clin Cancer Res; 2004 Jul; 10(14):4769-75. PubMed ID: 15269151
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. A new polymorphism (Ser362Thr) of the L-myc gene is not associated with lung adenocarcinoma risk and prognosis.
    Spinola M; Conti B; Ravagnani F; Fabbri A; Incarbone M; Cataldo I; Pira E; Pelucchi C; La Vecchia C; Dragani TA
    Eur J Cancer Prev; 2004 Feb; 13(1):87-9. PubMed ID: 15075794
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Is there any correlation between restriction fragment length polymorphism of the L-MYC gene and metastasis of human nonsmall cell lung cancer?
    Yaylim I; Isbir T; Oztürk O; Turna A; Işitmangil T; Zonüzi F; Camlica H
    Cancer Genet Cytogenet; 2002 Apr; 134(2):118-22. PubMed ID: 12034523
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Association of L-myc polymorphism with lung cancer susceptibility and prognosis in relation to age-selected controls and stratified cases.
    Shih CM; Kuo YY; Wang YC; Jian SL; Hsu YT; Wu HY; Guo MW; Wang YC
    Lung Cancer; 2002 May; 36(2):125-32. PubMed ID: 11955646
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. L-myc restriction fragment length polymorphism and histological pattern of invasion in lung adenocarcinoma.
    Suzuki H; Yamashiro K
    Oncol Rep; 2002; 9(2):345-7. PubMed ID: 11836605
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. L-myc genotype is associated with different susceptibility to lung cancer in smokers.
    Kumimoto H; Hamajima N; Nishimoto Y; Matsuo K; Shinoda M; Hatooka S; Ishizaki K
    Jpn J Cancer Res; 2002 Jan; 93(1):1-5. PubMed ID: 11802801
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Linkage disequilibrium pattern in the L-myc gene in Italian and Japanese non-small-cell lung-cancer patients.
    Spinola M; Nomoto T; Manenti G; Falvella FS; Brega Massone PP; Conti B; Cataldo I; Valagussa P; Incarbone M; Miyamoto K; Ushijima T; Dragani TA
    Int J Cancer; 2001 Sep; 95(5):329-31. PubMed ID: 11494234
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. L-myc genotypes in Hong Kong Chinese colorectal carcinoma patients.
    Ko JM; Cheung MH; Wong C; Lau K; Tang CM; Kwan MW; Lung ML
    Oncol Rep; 1999; 6(2):441-4. PubMed ID: 10023018
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. mycl genotypes and loss of heterozygosity in non-small-cell lung cancer.
    Fong KM; Kida Y; Zimmerman PV; Smith PJ
    Br J Cancer; 1996 Dec; 74(12):1975-8. PubMed ID: 8980399
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. L-MYC allelotype in renal cell carcinoma.
    Presti JC; Hinckley J; Reuter VE
    Cancer Genet Cytogenet; 1996 May; 88(1):66-8. PubMed ID: 8630982
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Alteration in length of telomeric repeats in lung cancer.
    Shirotani Y; Hiyama K; Ishioka S; Inyaku K; Awaya Y; Yonehara S; Yoshida Y; Inai K; Hiyama E; Hasegawa K
    Lung Cancer; 1994 Jul; 11(1-2):29-41. PubMed ID: 8081703
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Determination of the allelic frequencies of an L-myc and a p53 polymorphism in human lung cancer.
    Weston A; Ling-Cawley HM; Caporaso NE; Bowman ED; Hoover RN; Trump BF; Harris CC
    Carcinogenesis; 1994 Apr; 15(4):583-7. PubMed ID: 7908608
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Association of the SS genotype of the L-myc gene and loss of 18q sequences with a worse clinical prognosis in colorectal cancers.
    Young J; Buttenshaw R; Butterworth L; Ward M; Searle J; Leggett B; Chenevix-Trench G
    Oncogene; 1994 Apr; 9(4):1053-6. PubMed ID: 7907781
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. [Expression and co-expression of cellular oncogenes in the course of tumor progression in neuroendocrine lung tumors].
    Kogan EA; Shtabskiĭ AB; Sekamova SM; Sukhova NM; Mazurenko NN
    Arkh Patol; 1994; 56(2):16-21. PubMed ID: 8037585
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 2.